Skip to content
Latest News
Cyclo Therapeutics Stock Price Slips Despite FDA Approval of Trappsol

Cyclo Therapeutics (NASDAQ: CYTH) opened on Monday with a loss of 1.68%, losing premarket gains of 10% following promising news from the FDA. The clinical-stage biotech company dedicated to life-changing medicines anno

Ollie Martin - AskTraders News writer
OllieMartin
Riot Blockchain Down 9% with Crypto Sell-Off, Should You Buy The Dip?

Following a volatile end to last week’s trading, investors awoke this morning after a brutal weekend of selling across the crypto-board. Dubious sentiment mixed with clear-cut profit-taking led to a heavy bear run, wit

Ollie Martin - AskTraders News writer
OllieMartin
Bit Brother Stock Price Fell 13.2% As the Selling Pressure Intensified. What’s Next?

Bit Brother Ltd (NASDAQ: BTB) stock price fell 13.2% as the selling pressure n the stock intensified, driving its shares far below the $1 mark, putting it at risk of breaching the NASDAQ’s listing requirements. The speciality tea distributor’s sto

Simon Mugo
The Lucid Stock Price Fell 15.6% on SEC Investigation. Should You Buy It Now?

The Lucid Group Inc (NASDAQ: LCID) stock price fell 15.6% after revealing that it received a subpoena from the Securities and Exchange Commission (SEC) requesting it to produce certain documents relating to an investigation. Investors were spooked

Simon Mugo
Alset EHome International Down 40% Premarket On Stock Issuance Announcement

Alset EHome International (NASDAQ: AEI) is down 40% premarket this morning on the back of news about a stock placement. This follows an approximately 20% fall at the end of last week. This isn’t a good reaction to the

Tim Worstall
Tim Worstall
Unbelievable Stock Trading Statistics & Facts You’d Never Have Guessed

The stock market is an unusual beast. The size of it, the sto

avatar
Ruben Wunderlich
CF Acquisition Up 21% Premarket On Trump Link Up News

CF Acquisition (NASDAQ: CFVI) is up 21% premarket on the back of a 12% rise Friday. This is a result of talk about a link-up with Donald Trump and his media interests.  CF Acqu

Tim Worstall
Tim Worstall
Kanabo Share Price Rallied 6.3% Amid Hints of an E-Cigarette Product in the UK

Kanabo Group PLC (LON: KNB) share price rallied 6.3% after the UK Medicines and Healthcare products Regulatory Agency (MHRA) said it would start licensing e-cigarettes as medicines based on evidence that they could help people quit smoking. Dr Jun

Simon Mugo
Hammerson Price Edges Up On Share Repurchase Announcement, What Now?

Hammerson's (LON: HMSO) share price has edged up 2.6% on the back of an announcement of a share repurchase agreement. Hamm

Tim Worstall
Tim Worstall
Thungela Resources Jumps 14% As Demerger Gains Arrive

Thungela Resources (LON: TGA) is showing the benefits of the South African coal businesses’ demerger from

Tim Worstall
Tim Worstall
PetroTal Up 17% On Dispute Resolution In Peru, is it a Trading Opportunity?

PetroTal Corporation (LON: PTAL) is up 17% on the news that the dispute at the company’s operations in Peru has been, for the moment, resolved. The lesson here is how with a small company, a small operation, seemingly

Tim Worstall
Tim Worstall
Open Orphan Shares Spiked 2.8% as the hVIVO Business Grows. Should You Buy It?

Open Orphan PLC (LON: ORPH) share price spiked 2.8% higher after the company highlighted a report from SAB Biotherapeutics (NASDAQ: SABS) regarding a human challenge study conducted on its behalf by hVIVO. Open Orphan revealed that its subsidiary

Simon Mugo
Tavistock Up 20% On Booming Results – Will They Last? 

Tavistock Investments PLC (LON: TAVI) is up 20% this morning on the announcement of good results. The big question for traders is whether this advance is going to continue or whether there will be a fall back as habits

Tim Worstall
Tim Worstall
Analyst Alter JD Sports Share Price Targets Following Recent Fall

After recently hitting highs of 235.8p, JD Sports Fashion shares have declined, falling as low as 214p in the wake of the emergence of a new coronavirus variant.  On Frid

Sam Boughedda
Synairgen (SNG) Share Price Fell 3.53% Ahead of the Crucial Presentation. Is It a Buy?

Synairgen plc (LON: SNG) share price fell 3.53% at the open after the company revealed that it would present clinical data on the antiviral activity of its lead drug candidate SNG001 in patients with chronic obstructive pulmonary disease (COPD) and t

Simon Mugo
Didi Global Stock Tanks 14% on Plans for NYSE De-listing, What’s Next?

Didi Global witnessed a large sell-off in Friday trading, following a surprise announcement yesterday that the app-based services company will be delisting from the NYSE just a few months after the Chinese company’s IP

Ollie Martin - AskTraders News writer
OllieMartin
Fastly Stock Rallied on Friday, Here’s Why Analysts Suggest Buying

Fastly (NYSE: FSLY) stock rallied hard in January, creating new all-time highs as cloud computing, backed by increased working-from-home, started to weave its way into the agenda of mainstream tech. Since then, fastly

Ollie Martin - AskTraders News writer
OllieMartin
Smartsheet Stock Spikes 17% on Record-Breaking Earnings, What’s Next?

Software as a service; the once-niche is exploding throughout our digital lives - from commerce to accounts and everything in between, SaaS is proving to be one of the most successful emerging sectors within today’s te

Ollie Martin - AskTraders News writer
OllieMartin
Longeveron (LGVN) Stock Price Soared 41.1% on Lomecel-B Orphan Drug Designation

Longeveron Inc (NASDAQ: LGVN) stock price rallied 41.1% after the US Food and Drug Administration (FDA) awarded its Lomecel-B drug treatment for hypoplastic left heart syndrome orphan drug status. Investors cheered the move, evidenced by today’s r

Simon Mugo
Marvell Technology Stock Up 21% on Q3 Earnings, Revenue & EPS Beat

Marvell Technology (NASDAQ: MRVL) stock soared in Friday’s pre-market trading, reaching gains upwards of 20% after the technology and semiconductor company released impressive Q3 results postmarket Thursday. The high-e

Ollie Martin - AskTraders News writer
OllieMartin
Analysis Stocks Markets Strategies